A 10-step (!) solid-phase synthesis employing the traceless hydrazide linker provides efficient access to a 2-aminothiazole library (see scheme) that yielded access to a new class of tyrosine kinase inhibitors with dual selectivity for the vascular endothelial growth factor receptor VEGFR-2 and the Tie-2 receptor tyrosine kinases.
No takes yet. Share an insight, caveat, or question.
Stieber et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: